U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)

Date: September 1, 2011
Pages: 322
Price:
US$ 7,495.00
License [?]:
Publisher: iData Research Inc.
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery
ID: U2B5A7784CAEN
Leaflet:

Download PDF Leaflet

U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)
By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion. The market segments covered in the U.S. Markets for In Vitro Diagnostics 2011 include:
  • Immunochemistry,
    • Immunochemistry Analyzer
    • Immunology Diagnostic
    • Chemistry Diagnostics
    • Automated Urinalysis Instrument
  • Molecular Diagnostics
    • Molecular Diagnostics Reagent
    • Molecular Diagnostics Instrument
  • Hemostasis
    • Hemostasis Analyzer
    • Hemostasis Reagent
  • Hematology
    • Hematology Analyzer Market
    • Hematology Reagent
  • Blood Donor Screening
    • Blood Screening Analyzer
    • Blood Screening Assay Kit
  • Point-of-Care Testing
    • Blood Gas Testing
    • Urinalysis Testing
    • Blood Glucose Testing

In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food and Drug Administration (FDA) approved assays. That year, many technologies were well established and equipment markets were saturated. However, innovation, demand for testing and development of new assays will drive market growth.

Within the in vitro diagnostics market, companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.
EXECUTIVE SUMMARY

1.1 U.S.MARKET FOR IN VITRO DIAGNOSTICS
1.2 GROWTH TRENDS BY SEGMENT
1.3 IMMUNOCHEMISTRY MARKET
1.4 MOLECULAR DIAGNOSTICS MARKET
1.5 BLOOD DONOR SCREENING MARKET
1.6 HEMOSTASIS MARKET
1.7 HEMATOLOGY MARKET
1.8 POINT-OF-CARE TESTING MARKET
1.9 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
  2.2.1 Step 1: Project Initiation & Team Selection
  2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
  2.2.4 Step 4: Performing Primary Research
  2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  2.2.6 Step 6: Market Forecast and Analysis
  2.2.7 Step 7: Identify Strategic Opportunities
  2.2.8 Step 8: Final Review and Market Release
  2.2.9 Step 9: Customer Feedback and Market Monitoring

U.S. MARKET FOR IN VITRO DIAGNOSTICS

3.1 INTRODUCTION
3.2MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 MARKET DRIVERS AND LIMITERS
  3.4.1 Market Drivers
  3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
  3.5.1 Herfindahl Index
3.6 MERGERS AND ACQUISITIONS

IMMUNOCHEMISTRY MARKET

4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
  4.3.1 Immunochemistry Analyzer Market
  4.3.2 Immunoassay Market
    4.3.2.1 Immunoassay Analyzer Market
    4.3.2.2 Immunoassay Reagent Market
  4.3.3 Clinical Chemistry Market
    4.3.3.1 Clinical Chemistry Analyzer Market
      4.3.3.1.1 High-Volume Clinical Chemistry Analyzer Market
      4.3.3.1.2 Medium-Volume Clinical Chemistry Analyzer Market
      4.3.3.1.3 Low-Volume Clinical Chemistry Analyzer Market
    4.3.3.2 Clinical Chemistry Reagent Market
  4.3.4 Automated Urinalysis Analyzer Market
4.4 MARKET DRIVERS AND LIMITERS
  4.4.1 Market Drivers
  4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS

MOLECULAR DIAGNOSTICS MARKET

5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
  5.3.1 Molecular Diagnostics Instrument Market
  5.3.2 Molecular Diagnostics Assay Market
    5.3.2.1 Infectious Disease Assay Market
      5.3.2.1.1 Blood-Borne Virus Assay Market
      5.3.2.1.2 Women’s Health Assay Market
      5.3.2.1.3 MRSA and CMV Assay Market
    5.3.2.2 Genetic Diagnostics Assay Market
    5.3.2.3 Oncology Assay Market
5.4 MARKET DRIVERS AND LIMITERS
  5.4.1 Market Drivers
  5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS

BLOOD DONOR SCREENING MARKET

6.1 INTRODUCTION
6.2MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
    6.3.1.1 Blood Donor Screening Analyzer Market
    6.3.1.2 Blood Donor Screening Assay Market
6.4 MARKET DRIVERS AND LIMITERS
  6.4.1 Market Drivers
  6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS

HEMOSTASIS MARKET

7.1 INTRODUCTION
7.2MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
    7.3.1.1 Hemostasis Analyzer Market
    7.3.1.2 Hemostasis Reagent Market
7.4 MARKET DRIVERS AND LIMITERS
  7.4.1 Market Drivers
  7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS

HEMATOLOGY MARKET

8.1 INTRODUCTION
8.2MARKET OVERVIEW
8.3 MARKET FORECAST AND ANALYSIS
  8.3.1 Hematology Analyzer Market
    8.3.1.1 High-End Analyzer Market
    8.3.1.2 Low-End Analyzer Market
  8.3.2 Hematology Reagent Market
8.4 MARKET DRIVERS AND LIMITERS
  8.4.1 Market Drivers
  8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS

POINT-OF-CARE TESTING MARKET

9.1 INTRODUCTION
9.2MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
  9.3.1 Clinical Chemistry Market
    9.3.1.1 Clinical Chemistry Analyzer Market
    9.3.1.2 Clinical Chemistry Reagent Market
  9.3.2 Blood Gas Testing Market
    9.3.2.1 Blood Gas Analyzer Market
      9.3.2.1.1 Handheld Blood Gas Analyzer Market
      9.3.2.1.2 Decentralized Blood Gas Analyzer Market
    9.3.2.2 Blood Gas Reagent Market
  9.3.3 Point-of-Care Urinalysis Market
    9.3.3.1 Urinalysis Analyzer Market
    9.3.3.2 Urinalysis Test Strip Market
  9.3.4 Point-of-Care Blood Glucose Testing Market
    9.3.4.1 POC Blood Glucose Analyzer Market
    9.3.4.2 POC Blood Glucose Test Strip Market
9.4 MARKET DRIVERS AND LIMITERS
  9.4.1 Market Drivers
  9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

U.S. MARKET FOR IN VITRO DIAGNOSTICS

Figure 3 -1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 3 -2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S., 2007 – 2017
Figure 3 -3: Market Drivers and Limiters, In Vitro Diagnostics Market, 2010
Figure 3 -4: Leading Competitors, In Vitro Diagnostics Market, 2010 (Part 1 of 2)
Figure 3 -5: Leading Competitors, In Vitro Diagnostics Market, 2010 (Part 2 of 2)
Figure 3 -6: H-Index, In Vitro Diagnostics Market, U.S., 2010

IMMUNOCHEMISTRY MARKET

Figure 4 -1: Total Immunochemistry Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 4 -2: Total Immunochemistry Market, U.S., 2007 – 2017
Figure 4 -3: Immunochemistry Analyzer Market, U.S., 2007 – 2017
Figure 4 -4: Total Immunoassay Market, U.S., 2007 – 2017
Figure 4 -5: Immunoassay Analyzer Market, U.S., 2007 – 2017
Figure 4 -6: Immunoassay Market Test Groups
Figure 4 -7: Total Immunoassay Reagent Market, U.S., 2007 – 2017
Figure 4 -8: Immunoassay Tests Sold by Segment, U.S., 2007 – 2017
Figure 4 -9: Immunoassay Reagent ASP by Segment, U.S., 2007 – 2017 (US$)
Figure 4 -10: Immunoassay Reagent Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 4 -11: Total Clinical Chemistry Market, U.S., 2007 – 2017
Figure 4 -12: Total Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Figure 4 -13: High-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Figure 4 -14: Medium-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Figure 4 -15: Low-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Figure 4 -16: Total Clinical Chemistry Reagent Market, U.S., 2007 – 2017
Figure 4 -17: Clinical Chemistry Tests Sold by Segment, U.S., 2007 – 2017
Figure 4 -18: Clinical Chemistry Reagent ASP by Segment, U.S., 2007 – 2017
Figure 4 -19: Clinical Chemistry Reagent Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 4 -20: Automated Urinalysis Instrument Market, U.S., 2007 – 2017
Figure 4 -21: Market Drivers and Limiters, Immunochemistry Market, 2010
Figure 4 -22: Leading Competitors, Immunochemistry Market, 2010

MOLECULAR DIAGNOSTICS MARKET

Figure 5-1: Total Molecular Diagnostics Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 5-2: Total Molecular Diagnostics Market, U.S., 2007 – 2017
Figure 5-3: Molecular Diagnostics Instrument Market, U.S., 2007 – 2017
Figure 5-4: Total Molecular Diagnostics Assay Market, U.S., 2007 – 2017
Figure 5-5: Total Infectious Disease Assay Market, U.S., 2007 – 2017
Figure 5-6: Total Blood-Borne Virus Assay Market, U.S., 2007 – 2017
Figure 5-7: Blood-Borne Virus Tests Sold by Segment, U.S., 2007 – 2017
Figure 5-8: Blood-Borne Virus Assay ASP by Segment, U.S., 2007 – 2017 (US$)
Figure 5-9: Blood-Borne Virus Assay Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 5-10: Total Women’s Health Assay Market, U.S., 2007 – 2017
Figure 5-11: Total Women’s Health Tests Sold by Segment, U.S., 2007 – 2017.
Figure 5-12: Total Women’s Health Assay ASP by Segment, U.S., 2007 – 2017 (US$)
Figure 5-13: Total Women’s Health Assay Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 5-14: Total MRSA and CMV Assay Market, U.S., 2007 – 2017
Figure 5-15: Total MRSA and CMV Tests Sold by Segment, U.S., 2007 – 2017
Figure 5-16: Total MRSA and CMV Assay ASP by Segment, U.S., 2007 – 2017 (US$)
Figure 5-17: Total MRSA and CMV Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 5-18: Total Genetic Diagnostics Assay Market, U.S., 2007 – 2017
Figure 5-19: Total Genetic Diagnostics Tests Sold by Segment, U.S., 2007 – 2017
Figure 5-20: Total Genetic Diagnostics Assay ASP by Segment, U.S., 2007 – 2017
Figure 5-21: Total Genetic Diagnostics Assay Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 5-22: Total Oncology Assay Market, U.S., 2007 – 2017
Figure 5-23: Total Oncology Tests Sold by Segment, U.S., 2007 – 2017
Figure 5-24: Total Oncology Assay ASP by Segment, U.S., 2007 – 2017 (US$)
Figure 5-25: Total Oncology Assay Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 5-26: Market Drivers and Limiters, Molecular Diagnostics Market, 2010
Figure 5-27: Leading Competitors, Molecular Diagnostics Market, 2010

BLOOD DONOR SCREENING MARKET

Figure 6-1: Total Blood Donor Screening Market by Segment, U.S., 2007 – 2017(US$M)
Figure 6-2: Total Blood Donor Screening Market, U.S., 2007 – 2017
Figure 6-3: Blood Donor Screening Analyzer Market, U.S., 2007 – 2017
Figure 6-4: Total Blood Donor Screening Assay Market, U.S., 2007 – 2017
Figure 6-5: Blood Donor Screening Units Sold by Segment, U.S., 2007 – 2017.
Figure 6-6: Blood Donor Screening Assay ASP by Segment, U.S., 2007 – 2017 (US$)
Figure 6-7: Blood Donor Screening Assay Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 6-8: Market Drivers and Limiters, Blood Donor Screening Market, 2010
Figure 6-9: Leading Competitors, Blood Donor Screening Market, 2010

HEMOSTASIS MARKET

Figure 7-1: Hemophilia Classification
Figure 7-2: Total Hemostasis Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 7-3: Total Hemostasis Market, U.S., 2007 – 2017
Figure 7-4: Hemostasis Analyzer Market, U.S., 2007 – 2017
Figure 7-5: Hemostasis Reagent Market, U.S., 2007 – 2017
Figure 7-6: Market Drivers and Limiters, Hemostasis Market, 2010
Figure 7-7: Leading Competitors, Hemostasis Market, 2010

HEMATOLOGY MARKET

Figure 8-1: Total Hematology Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 8-2: Total Hematology Market, U.S., 2007 – 2017
Figure 8-3: Total Hematology Analyzer Market, U.S., 2007 – 2017
Figure 8-4: High-End Analyzer Market, U.S., 2007 – 2017
Figure 8-5: Low-End Analyzer Market, U.S., 2007 – 2017
Figure 8-6: Hematology Reagent Market, U.S., 2007 – 2017
Figure 8-7: Market Drivers and Limiters, Hematology Market, 2010
Figure 8-8: Leading Competitors, Hematology Market, 2010

POINT-OF-CARE TESTING MARKET

Figure 9-1: Total POC Testing Market by Segment, U.S., 2007 – 2017 (US$M)
Figure 9-2: Total POC Testing Market Segments by Percentage, U.S., 2007 – 2017
Figure 9-3: Total POC Testing Market by Product Type, U.S., 2007 – 2017
Figure 9-4: Total POC Testing Market, U.S., 2007 – 2017
Figure 9-5: Clinical Chemistry Market, U.S., 2007 – 2017
Figure 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Figure 9-7: Clinical Chemistry Reagent Market, U.S., 2007 – 2017
Figure 9-8: Blood Gas Testing Market, U.S., 2007 – 2017
Figure 9-9: Total Blood Gas Analyzer Market, U.S., 2007 – 2017
Figure 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 – 2017
Figure 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 – 2017
Figure 9-12: Total Blood Gas Reagent Market, U.S., 2007 – 2017
Figure 9-13: Blood Gas Reagent Units Sold by Packaging Type Market, U.S., 2007 – 2017
Figure 9-14: Blood Gas Reagent ASP by Packaging Type Market, U.S., 2007 – 2017 (US$)
Figure 9-15: Blood Gas Reagent Market by Packaging Type, U.S., 2007 – 2017 (US$M)
Figure 9-16: POC Urinalysis Market, U.S., 2007 – 2017
Figure 9-17: Urinalysis Analyzer Market, U.S., 2007 – 2017
Figure 9-18: POC Urinalysis Test Strip Market, U.S., 2007 – 2017
Figure 9-19: POC Blood Glucose Testing Market, U.S., 2007 – 2017
Figure 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 – 2017
Figure 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 – 2017
Figure 9-22: Market Drivers and Limiters, Point-of-Care Testing Market, 2010
Figure 9-23: Leading Competitors, Point-of-Care Testing Market, 2010

ABBREVIATIONS

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING

Figure 11-1: Market Proportion by Testing Setting, 2010

LIST OF CHARTS

EXECUTIVE SUMMARY

Chart 1-1: Total U.S. In Vitro Diagnostics Market by Segment, U.S., 2010
Chart 1-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S., 2007 – 2017
Chart 1-3: Immunochemistry Assay Volume Growth Rates by Segment, U.S., 2007 – 2017
Chart 1-4: Infectious Disease Assay Market by Segment, U.S., 2010
Chart 1-5: Blood Donor Screening Market, U.S., 2010
Chart 1-6: Hemostasis Market by Segment, U.S., 2010
Chart 1-7: Hematology Market by Segment, U.S., 2007 – 2017
Chart 1-8: POC Testing Market, U.S., 2007 – 2017
Chart 1-9: Leading Competitors, In Vitro Diagnostics Market, U.S., 2010

RESEARCH METHODOLOGY

U.S. MARKET FOR IN VITRO DIAGNOSTICS

Chart 3 -1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 – 2017
Chart 3 -2: Total In Vitro Diagnostics Market by Segment, U.S., 2010
Chart 3 -3: Total In Vitro Diagnostics Market by Segment, U.S., 2017
Chart 3 -4: Growth Rates by Segment, In Vitro Diagnostics Market, U.S., 2007 – 2017
Chart 3 -5: Leading Competitors, In Vitro Diagnostics Market, 2010
Chart 3 -6: H-Index, In Vitro Diagnostics Market, U.S., 2010

IMMUNOCHEMISTRY MARKET

Chart 4 -1: Total Immunochemistry Market by Segment, U.S., 2007 – 2017
Chart 4 -2: Total Immunochemistry Market by Segment, U.S., 2010
Chart 4 -3: Total Immunochemistry Market by Segment, U.S., 2017
Chart 4 -4: Total Immunochemistry Market, U.S., 2007 – 2017
Chart 4 -5: Immunochemistry Analyzer Market, U.S., 2007 – 2017
Chart 4 -6: Total Immunoassay Market, U.S., 2007 – 2017
Chart 4 -7: Immunoassay Analyzer Market, U.S., 2007 – 2017
Chart 4 -8: Total Immunoassay Reagent Market, U.S., 2007 – 2017
Chart 4 -9: Cardiovascular Reagent Market, U.S., 2007 – 2017
Chart 4 -10: Cancer Reagent Market, U.S., 2007 – 2017
Chart 4 -11: Infectious Disease Reagent Market, U.S., 2007 – 2017
Chart 4 -12: Metabolic Reagent Market, U.S., 2007 – 2017
Chart 4 -13: Endocrine Reagent Market, U.S., 2007 – 2017
Chart 4 -14: Reproductive and Fertility Reagent Market, U.S., 2007 – 2017
Chart 4 -15: Autoimmune Reagent Market, U.S., 2007 – 2017
Chart 4 -16: Total Clinical Chemistry Market, U.S., 2007 – 2017
Chart 4 -17: Total Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Chart 4 -18: High-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Chart 4 -19: Medium-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Chart 4 -20: Low-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Chart 4 -21: Total Clinical Chemistry Reagent Market, U.S., 2007 – 2017
Chart 4 -22: General Chemistry Reagent Market, U.S., 2007 – 2017
Chart 4 -23: Specific Protein Reagent Market, U.S., 2007 – 2017
Chart 4 -24: Therapeutic Drug Monitoring Reagent Market, U.S., 2007 – 2017
Chart 4 -25: Drugs of Abuse Reagent Market, U.S., 2007 – 2017
Chart 4 -26: Special Chemistry Reagent Market, U.S., 2007 – 2017
Chart 4 -27: Automated Urinalysis Instrument Market, U.S., 2007 – 2017
Chart 4 -28: Leading Competitors, Immunochemistry Market, 2010

MOLECULAR DIAGNOSTICS MARKET

Chart 5-1: Total Molecular Diagnostics Market by Segment, U.S., 2007 – 2017
Chart 5-2: Total Molecular Diagnostics Market by Segment, U.S., 2010
Chart 5-3: Total Molecular Diagnostics Market by Segment, U.S., 2017
Chart 5-4: Total Molecular Diagnostics Market, U.S., 2007 – 2017
Chart 5-5: Molecular Diagnostics Instrument Market, U.S., 2007 – 2017
Chart 5-6: Total Molecular Diagnostics Assay Market, U.S., 2007 – 2017
Chart 5-7: Total Infectious Disease Assay Market, U.S., 2007 – 2017
Chart 5-8: Total Blood-Borne Virus Assay Market, U.S., 2007 – 2017
Chart 5-9: HIV Assay Market, U.S., 2007 – 2017
Chart 5-10: HCV Assay Market, U.S., 2007 – 2017
Chart 5-11: HBV Assay Market, U.S., 2007 – 2017
Chart 5-12: Total Women’s Health Assay Market, U.S., 2007 – 2017
Chart 5-13: HPV Assay Market, U.S., 2007 – 2017
Chart 5-14: HSV Assay Market, U.S., 2007 – 2017
Chart 5-15: CT/GC Assay Market, U.S., 2007 – 2017
Chart 5-16: Total MRSA and CMV Assay Market, U.S., 2007 – 2017
Chart 5-17: MRSA Assay Market, U.S., 2007 – 2017
Chart 5-18: CMV Assay Market, U.S., 2007 – 2017
Chart 5-19: Total Genetic Diagnostics Assay Market, U.S., 2007 – 2017
Chart 5-20: CF Assay Market, U.S., 2007 – 2017
Chart 5-21: Inherited Thrombophilia Assay Market, U.S., 2007 – 2017
Chart 5-22: Total Oncology Assay Market, U.S., 2007 – 2017
Chart 5-23: Breast Cancer Assay Market, U.S., 2007 – 2017
Chart 5-24: Colorectal Cancer Assay Market, U.S., 2007 – 2017
Chart 5-25: Prostate Cancer Assay Market, U.S., 2007 – 2017
Chart 5-26: Leading Competitors, Molecular Diagnostics Market, 2010

BLOOD DONOR SCREENING MARKET

Chart 6-1: Total Blood Donor Screening Market by Segment, U.S., 2007 – 2017
Chart 6-2: Total Blood Donor Screening Market by Segment, U.S., 2010
Chart 6-3: Total Blood Donor Screening Market by Segment, U.S., 2017
Chart 6-4: Total Blood Donor Screening Market, U.S., 2007 – 2017
Chart 6-5: Blood Donor Screening Analyzer Market, U.S., 2007 – 2017
Chart 6-6: Blood Donor Screening Assay Market, U.S., 2007 – 2017
Chart 6-7: Combined Assay Market, U.S., 2007 – 2017
Chart 6-8: WNV Assay Market, U.S., 2007 – 2017
Chart 6-9: HIV Assay Market, U.S., 2007 – 2017
Chart 6-10: HCV Assay Market, U.S., 2007 – 2017
Chart 6-11: HBV Assay Market, U.S., 2007 – 2017
Chart 6-12: Leading Competitors, Blood Donor Screening Reagent Market, U.S., 2007 – 2017

HEMOSTASIS MARKET

Chart 7-1: Total Hemostasis Market by Segment, U.S., 2007 – 2017
Chart 7-2: Total Hemostasis Market by Segment, U.S., 2010
Chart 7-3: Total Hemostasis Market by Segment, U.S., 2017
Chart 7-4: Total Hemostasis Market, U.S., 2007 – 2017
Chart 7-5: Hemostasis Analyzer Market, U.S., 2007 – 2017
Chart 7-6: Hemostasis Reagent Market, U.S., 2007 – 2017
Chart 7-7: Leading Competitors, Hemostasis Market, 2010

HEMATOLOGY MARKET

Chart 8-1: Total Hematology Market by Segment, U.S., 2007 – 2017
Chart 8-2: Total Hematology Market by Segment, U.S., 2010
Chart 8-3: Total Hematology Market by Segment, U.S., 2017
Chart 8-4: Total Hematology Market, U.S., 2007 – 2017
Chart 8-5: Total Hematology Analyzer Market, U.S., 2007 – 2017
Chart 8-6: High-End Analyzer Market, U.S., 2007 – 2017
Chart 8-7: Low-End Analyzer Market, U.S., 2007 – 2017
Chart 8-8: Hematology Reagent Market, U.S., 2007 – 2017
Chart 8-9: Leading Competitors, Hematology Market, 2010

POINT-OF-CARE TESTING MARKET

Chart 9-1: Total POC Testing Market by Segment, U.S., 2007 – 2017
Chart 9-2: Total POC Testing Market by Segment, U.S., 2010
Chart 9-3: Total POC Testing Market by Segment, U.S., 2017
Chart 9-4: Total POC Testing Market, U.S., 2007 – 2017
Chart 9-5: Total Clinical Chemistry Market, U.S., 2007 – 2017
Chart 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
Chart 9-7: Clinical Chemistry Reagent Market, U.S., 2007 – 2017
Chart 9-8: Blood Gas Testing Market, U.S., 2007 – 2017
Chart 9-9: Total Blood Gas Analyzer Market, U.S., 2007 – 2017
Chart 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 – 2017
Chart 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 – 2017
Chart 9-12: Total Blood Gas Reagent Market, U.S., 2007 – 2017
Chart 9-13: Single-Use Cartridge Market, U.S., 2007 – 2017
Chart 9-14: Multi-Use Cartridge Market, U.S., 2007 – 2017
Chart 9-15: Other Reagent Market, U.S., 2007 – 2017
Chart 9-16: POC Urinalysis Market, U.S., 2007 – 2017
Chart 9-17: Urinalysis Analyzer Market, U.S., 2007 – 2017
Chart 9-18: POC Urinalysis Test Strip Market, U.S., 2007 – 2017
Chart 9-19: POC Blood Glucose Testing Market, U.S., 2007 – 2017
Chart 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 – 2017
Chart 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 – 2017
Chart 9-22: Leading Competitors, Point-of-Care Testing Market, 2010

ABBREVIATIONS

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING
In Vitro Diagnostics: World Market Outlook 2013-2023 US$ 2,635.00 Aug, 2013 · 137 pages
Worldwide Point of Care Diagnostic Test Markets US$ 2,800.00 Dec, 2010 · 390 pages
In Vitro Diagnostics Markets in China US$ 4,000.00 May, 2013 · 170 pages

Ask Your Question

U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: